Back to Results
First PageMeta Content
Biology / Organic chemistry / Enterobacteria / Enantiopure drugs / Antibiotics / Mecillinam / Beta-lactamase / Pivmecillinam / Norfloxacin / Beta-lactam antibiotics / Microbiology / Medicine


Rationale for the EUCAST clinical breakpoints
Add to Reading List

Document Date: 2010-12-15 12:28:46

Open Document

File Size: 214,54 KB

Share Result on Facebook

Continent

Europe / /

MedicalCondition

uncomplicated urinary tract infections / uncomplicated urinary tract infection / Pseudomonas / infections / Enterobacteriaceae Pseudomonas / breakpoints Pseudomonas / /

Organization

European Society for Clinical Microbiology and Infectious Diseases / Infectious Diseases / European Committee on Antimicrobial Susceptibility Testing / European Centre for Disease Prevention and Control / European Society for Clinical Microbiology / /

Person

DIN NWGA SRGA / /

Position

CLSI2 General / /

Product

norfloxacin / /

Technology

Alpha / Pharmacokinetics / Pharmacodynamics / /

URL

http /

SocialTag